Fate Therapeutics (FATE) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to $122.4 million.
- Fate Therapeutics' Non-Current Assets fell 3371.09% to $122.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $562.9 million, marking a year-over-year decrease of 2437.27%. This contributed to the annual value of $148.8 million for FY2024, which is 1482.28% down from last year.
- Per Fate Therapeutics' latest filing, its Non-Current Assets stood at $122.4 million for Q3 2025, which was down 3371.09% from $141.2 million recorded in Q2 2025.
- Over the past 5 years, Fate Therapeutics' Non-Current Assets peaked at $302.4 million during Q2 2021, and registered a low of $122.4 million during Q3 2025.
- For the 5-year period, Fate Therapeutics' Non-Current Assets averaged around $204.2 million, with its median value being $192.6 million (2023).
- In the last 5 years, Fate Therapeutics' Non-Current Assets soared by 16673.78% in 2021 and then tumbled by 3371.09% in 2025.
- Quarter analysis of 5 years shows Fate Therapeutics' Non-Current Assets stood at $288.0 million in 2021, then fell by 29.36% to $203.5 million in 2022, then dropped by 14.16% to $174.7 million in 2023, then decreased by 14.82% to $148.8 million in 2024, then fell by 17.72% to $122.4 million in 2025.
- Its Non-Current Assets stands at $122.4 million for Q3 2025, versus $141.2 million for Q2 2025 and $150.5 million for Q1 2025.